SynthesisBMC cardiovascular disorders2026
Difference of pericoronary adipose tissue attenuation between culprit and non-culprit lesions in acute coronary syndrome: a systematic review and meta-analysis.
Synthesis in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundPericoronary adipose tissue (PCAT) attenuation, a non-invasive marker of coronary inflammation, predicts adverse cardiovascular events. However, the extent of localized inflammation at the culprit lesion site in acute coronary syndrome (ACS) has not been systematically quantified. We aimed to meta-analyze the difference in PCAT attenuation between culprit and non-culprit lesions in patients with ACS.
methodsWe systematically searched PubMed and Embase for studies comparing PCAT attenuation between culprit and non-culprit lesions/vessels in ACS patients. A random-effects model was used to calculate the pooled mean difference (MD). Pre-specified subgroup and meta-regression analyses were performed to explore heterogeneity.
resultsTwelve studies with 826 patients were included. Meta-analysis was performed in 11 studies comprising 12 cohorts (461 culprit/731 non-culprit lesions and 388 culprit/487 non-culprit vessels). PCAT attenuation was significantly higher around culprit sites compared to non-culprit sites (MD 4.95 HU, 95% CI: 2.62–7.27, p < 0.001), with substantial heterogeneity (I²=89%). Subgroup analysis revealed a significantly greater effect size when PCAT was measured at the perilesional level (MD 7.50 HU) versus the vessel level (MD 2.43 HU). Meta-regression identified the analysis lesion unit (p = 0.002) and ACS subtype (p = 0.003) as major sources of heterogeneity.
conclusionThis meta-analysis provides consistent evidence that culprit lesions in ACS are characterized by a measurable and highly localized increase in pericoronary inflammation. A perilesional measurement approach may better capture this focal inflammatory signal, highlighting the potential of PCAT attenuation for identifying culprit lesion in ACS.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.